Global Streptokinase Market
Global Streptokinase Market

Streptokinase Comprehensive Study by Application (Myocardial Infarction (MI), Deep vein thrombosis, Pulmonary embolism, Others), Way of ordering (Walk-in, Application, Online) Players and Region - Global Market Outlook to 2024

Streptokinase Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Feb 2019 Edition 229 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Streptokinase Market Overview:
Streptokinase is referring as a sterile, which is a purified preparation of a protein consists of bacteria, elaborated by group C (beta) that is hemolytic streptococci. Streptokinase is supplied as a lyophilized white powder which contains 25 mg cross-linked gelatin polypeptides, sodium hydroxide to adjust pH, 25 mg sodium L-glutamate and 100 mg Albumin (Human) per vial or infusion bottle as stabilizers. The preparation of it contains no preservatives and it is intended for intracoronary and intravenous administration. Streptokinase is normally used to dissolve blood clots which have been formed in the blood vessels. It is immediately used after the symptoms of a heart attack occur to improve the patient survival. This medicine can also be used to treat the blood clots in the legs and the lungs.

Market Drivers
  • Increasing geriatric population

Market Trend
  • Rising awareness related to personal healthcare
  • Growing camps associated with the health knowledge

Restraints
  • Side effects associated with the intake of serratiopeptidase

Opportunities
  • Growth potential offered by emerging countries

Challenges
  • The high cost associated with the products


Competitive Landscape:
The market is fragmented by key vendors who are focusing on production technologies, improving efficiency and shelf life. Growth opportunities can be captured by tracking the ongoing process improvement and financial flexibility to invest in optimal strategies
Some of the key players profiled in the report are SAMARTH PHARMA (India), Biocon (India), Kee Pharma (India), Dabur (India), Biosena (India), Wanbang Biopharma (China), Qingdao GD Biotechnology Pharmaceutical (China), Aristo Pharmaceuticals (India), Neiss Labs (India) and Ahaan Healthcare Pvt Ltd. (AHPL) (India). Additionally, following companies can also be profiled that are part of our coverage like TTK HealthCare (India), Incepta pharmaceuticals limited (Bangladesh) and Cadila (India). Considering Market by Way of ordering, the sub-segment i.e. Walk-in will boost the Streptokinase market.

Market Highlights:

Sirona Biochem Corp. announced that partner Jiangsu Wanbang Biopharmaceuticals has confirmed an Investigational New Drug (IND) submission to China's Food and Drug Administration (CFDA) for its SGLT2 inhibitor. The application will be reviewed by the CFDA for acceptance into clinical trials

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Streptokinase market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Streptokinase market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Streptokinase Manufacturers, Streptokinase Distributors/Traders/Wholesalers, Streptokinase Subcomponent Manufacturers, Industry Association and Downstream Vendors.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Application
  • Myocardial Infarction (MI)
  • Deep vein thrombosis
  • Pulmonary embolism
  • Others
By Way of ordering
  • Walk-in
  • Application
  • Online

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing geriatric population
    • 3.3. Market Challenges
      • 3.3.1. The high cost associated with the products
    • 3.4. Market Trends
      • 3.4.1. Rising awareness related to personal healthcare
      • 3.4.2. Growing camps associated with the health knowledge
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Streptokinase, by Application, Way of ordering and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Streptokinase (Value)
      • 5.2.1. Global Streptokinase by: Application (Value)
        • 5.2.1.1. Myocardial Infarction (MI)
        • 5.2.1.2. Deep vein thrombosis
        • 5.2.1.3. Pulmonary embolism
        • 5.2.1.4. Others
      • 5.2.2. Global Streptokinase by: Way of ordering (Value)
        • 5.2.2.1. Walk-in
        • 5.2.2.2. Application
        • 5.2.2.3. Online
      • 5.2.3. Global Streptokinase Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Streptokinase: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. SAMARTH PHARMA (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biocon (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Kee Pharma (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Dabur (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biosena (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Wanbang Biopharma (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Qingdao GD Biotechnology Pharmaceutical (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Aristo Pharmaceuticals (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Neiss Labs (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ahaan Healthcare Pvt Ltd. (AHPL) (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Streptokinase Sale, by Application, Way of ordering and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Streptokinase (Value)
      • 7.2.1. Global Streptokinase by: Application (Value)
        • 7.2.1.1. Myocardial Infarction (MI)
        • 7.2.1.2. Deep vein thrombosis
        • 7.2.1.3. Pulmonary embolism
        • 7.2.1.4. Others
      • 7.2.2. Global Streptokinase by: Way of ordering (Value)
        • 7.2.2.1. Walk-in
        • 7.2.2.2. Application
        • 7.2.2.3. Online
      • 7.2.3. Global Streptokinase Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Streptokinase: by Application(USD Million)
  • Table 2. Streptokinase Myocardial Infarction (MI) , by Region USD Million (2013-2018)
  • Table 3. Streptokinase Deep vein thrombosis , by Region USD Million (2013-2018)
  • Table 4. Streptokinase Pulmonary embolism , by Region USD Million (2013-2018)
  • Table 5. Streptokinase Others , by Region USD Million (2013-2018)
  • Table 6. Streptokinase: by Way of ordering(USD Million)
  • Table 7. Streptokinase Walk-in , by Region USD Million (2013-2018)
  • Table 8. Streptokinase Application , by Region USD Million (2013-2018)
  • Table 9. Streptokinase Online , by Region USD Million (2013-2018)
  • Table 10. South America Streptokinase, by Country USD Million (2013-2018)
  • Table 11. South America Streptokinase, by Application USD Million (2013-2018)
  • Table 12. South America Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 13. Brazil Streptokinase, by Application USD Million (2013-2018)
  • Table 14. Brazil Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 15. Argentina Streptokinase, by Application USD Million (2013-2018)
  • Table 16. Argentina Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 17. Rest of South America Streptokinase, by Application USD Million (2013-2018)
  • Table 18. Rest of South America Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 19. Asia Pacific Streptokinase, by Country USD Million (2013-2018)
  • Table 20. Asia Pacific Streptokinase, by Application USD Million (2013-2018)
  • Table 21. Asia Pacific Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 22. China Streptokinase, by Application USD Million (2013-2018)
  • Table 23. China Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 24. Japan Streptokinase, by Application USD Million (2013-2018)
  • Table 25. Japan Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 26. India Streptokinase, by Application USD Million (2013-2018)
  • Table 27. India Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 28. South Korea Streptokinase, by Application USD Million (2013-2018)
  • Table 29. South Korea Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 30. Taiwan Streptokinase, by Application USD Million (2013-2018)
  • Table 31. Taiwan Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 32. Australia Streptokinase, by Application USD Million (2013-2018)
  • Table 33. Australia Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Streptokinase, by Application USD Million (2013-2018)
  • Table 35. Rest of Asia-Pacific Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 36. Europe Streptokinase, by Country USD Million (2013-2018)
  • Table 37. Europe Streptokinase, by Application USD Million (2013-2018)
  • Table 38. Europe Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 39. Germany Streptokinase, by Application USD Million (2013-2018)
  • Table 40. Germany Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 41. France Streptokinase, by Application USD Million (2013-2018)
  • Table 42. France Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 43. Italy Streptokinase, by Application USD Million (2013-2018)
  • Table 44. Italy Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 45. United Kingdom Streptokinase, by Application USD Million (2013-2018)
  • Table 46. United Kingdom Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 47. Netherlands Streptokinase, by Application USD Million (2013-2018)
  • Table 48. Netherlands Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 49. Rest of Europe Streptokinase, by Application USD Million (2013-2018)
  • Table 50. Rest of Europe Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 51. MEA Streptokinase, by Country USD Million (2013-2018)
  • Table 52. MEA Streptokinase, by Application USD Million (2013-2018)
  • Table 53. MEA Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 54. Middle East Streptokinase, by Application USD Million (2013-2018)
  • Table 55. Middle East Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 56. Africa Streptokinase, by Application USD Million (2013-2018)
  • Table 57. Africa Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 58. North America Streptokinase, by Country USD Million (2013-2018)
  • Table 59. North America Streptokinase, by Application USD Million (2013-2018)
  • Table 60. North America Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 61. United States Streptokinase, by Application USD Million (2013-2018)
  • Table 62. United States Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 63. Canada Streptokinase, by Application USD Million (2013-2018)
  • Table 64. Canada Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 65. Mexico Streptokinase, by Application USD Million (2013-2018)
  • Table 66. Mexico Streptokinase, by Way of ordering USD Million (2013-2018)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Streptokinase: by Application(USD Million)
  • Table 78. Streptokinase Myocardial Infarction (MI) , by Region USD Million (2019-2024)
  • Table 79. Streptokinase Deep vein thrombosis , by Region USD Million (2019-2024)
  • Table 80. Streptokinase Pulmonary embolism , by Region USD Million (2019-2024)
  • Table 81. Streptokinase Others , by Region USD Million (2019-2024)
  • Table 82. Streptokinase: by Way of ordering(USD Million)
  • Table 83. Streptokinase Walk-in , by Region USD Million (2019-2024)
  • Table 84. Streptokinase Application , by Region USD Million (2019-2024)
  • Table 85. Streptokinase Online , by Region USD Million (2019-2024)
  • Table 86. South America Streptokinase, by Country USD Million (2019-2024)
  • Table 87. South America Streptokinase, by Application USD Million (2019-2024)
  • Table 88. South America Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 89. Brazil Streptokinase, by Application USD Million (2019-2024)
  • Table 90. Brazil Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 91. Argentina Streptokinase, by Application USD Million (2019-2024)
  • Table 92. Argentina Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 93. Rest of South America Streptokinase, by Application USD Million (2019-2024)
  • Table 94. Rest of South America Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 95. Asia Pacific Streptokinase, by Country USD Million (2019-2024)
  • Table 96. Asia Pacific Streptokinase, by Application USD Million (2019-2024)
  • Table 97. Asia Pacific Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 98. China Streptokinase, by Application USD Million (2019-2024)
  • Table 99. China Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 100. Japan Streptokinase, by Application USD Million (2019-2024)
  • Table 101. Japan Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 102. India Streptokinase, by Application USD Million (2019-2024)
  • Table 103. India Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 104. South Korea Streptokinase, by Application USD Million (2019-2024)
  • Table 105. South Korea Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 106. Taiwan Streptokinase, by Application USD Million (2019-2024)
  • Table 107. Taiwan Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 108. Australia Streptokinase, by Application USD Million (2019-2024)
  • Table 109. Australia Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 110. Rest of Asia-Pacific Streptokinase, by Application USD Million (2019-2024)
  • Table 111. Rest of Asia-Pacific Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 112. Europe Streptokinase, by Country USD Million (2019-2024)
  • Table 113. Europe Streptokinase, by Application USD Million (2019-2024)
  • Table 114. Europe Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 115. Germany Streptokinase, by Application USD Million (2019-2024)
  • Table 116. Germany Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 117. France Streptokinase, by Application USD Million (2019-2024)
  • Table 118. France Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 119. Italy Streptokinase, by Application USD Million (2019-2024)
  • Table 120. Italy Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 121. United Kingdom Streptokinase, by Application USD Million (2019-2024)
  • Table 122. United Kingdom Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 123. Netherlands Streptokinase, by Application USD Million (2019-2024)
  • Table 124. Netherlands Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 125. Rest of Europe Streptokinase, by Application USD Million (2019-2024)
  • Table 126. Rest of Europe Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 127. MEA Streptokinase, by Country USD Million (2019-2024)
  • Table 128. MEA Streptokinase, by Application USD Million (2019-2024)
  • Table 129. MEA Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 130. Middle East Streptokinase, by Application USD Million (2019-2024)
  • Table 131. Middle East Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 132. Africa Streptokinase, by Application USD Million (2019-2024)
  • Table 133. Africa Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 134. North America Streptokinase, by Country USD Million (2019-2024)
  • Table 135. North America Streptokinase, by Application USD Million (2019-2024)
  • Table 136. North America Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 137. United States Streptokinase, by Application USD Million (2019-2024)
  • Table 138. United States Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 139. Canada Streptokinase, by Application USD Million (2019-2024)
  • Table 140. Canada Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 141. Mexico Streptokinase, by Application USD Million (2019-2024)
  • Table 142. Mexico Streptokinase, by Way of ordering USD Million (2019-2024)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Streptokinase: by Application USD Million (2013-2018)
  • Figure 5. Global Streptokinase: by Way of ordering USD Million (2013-2018)
  • Figure 6. South America Streptokinase Share (%), by Country
  • Figure 7. Asia Pacific Streptokinase Share (%), by Country
  • Figure 8. Europe Streptokinase Share (%), by Country
  • Figure 9. MEA Streptokinase Share (%), by Country
  • Figure 10. North America Streptokinase Share (%), by Country
  • Figure 11. Global Streptokinase share by Players 2018 (%)
  • Figure 12. Global Streptokinase share by Players (Top 3) 2018(%)
  • Figure 13. Global Streptokinase share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. SAMARTH PHARMA (India) Revenue, Net Income and Gross profit
  • Figure 16. SAMARTH PHARMA (India) Revenue: by Geography 2018
  • Figure 17. Biocon (India) Revenue, Net Income and Gross profit
  • Figure 18. Biocon (India) Revenue: by Geography 2018
  • Figure 19. Kee Pharma (India) Revenue, Net Income and Gross profit
  • Figure 20. Kee Pharma (India) Revenue: by Geography 2018
  • Figure 21. Dabur (India) Revenue, Net Income and Gross profit
  • Figure 22. Dabur (India) Revenue: by Geography 2018
  • Figure 23. Biosena (India) Revenue, Net Income and Gross profit
  • Figure 24. Biosena (India) Revenue: by Geography 2018
  • Figure 25. Wanbang Biopharma (China) Revenue, Net Income and Gross profit
  • Figure 26. Wanbang Biopharma (China) Revenue: by Geography 2018
  • Figure 27. Qingdao GD Biotechnology Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 28. Qingdao GD Biotechnology Pharmaceutical (China) Revenue: by Geography 2018
  • Figure 29. Aristo Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 30. Aristo Pharmaceuticals (India) Revenue: by Geography 2018
  • Figure 31. Neiss Labs (India) Revenue, Net Income and Gross profit
  • Figure 32. Neiss Labs (India) Revenue: by Geography 2018
  • Figure 33. Ahaan Healthcare Pvt Ltd. (AHPL) (India) Revenue, Net Income and Gross profit
  • Figure 34. Ahaan Healthcare Pvt Ltd. (AHPL) (India) Revenue: by Geography 2018
  • Figure 35. Global Streptokinase: by Application USD Million (2019-2024)
  • Figure 36. Global Streptokinase: by Way of ordering USD Million (2019-2024)
  • Figure 37. South America Streptokinase Share (%), by Country
  • Figure 38. Asia Pacific Streptokinase Share (%), by Country
  • Figure 39. Europe Streptokinase Share (%), by Country
  • Figure 40. MEA Streptokinase Share (%), by Country
  • Figure 41. North America Streptokinase Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • SAMARTH PHARMA (India)
  • Biocon (India)
  • Kee Pharma (India)
  • Dabur (India)
  • Biosena (India)
  • Wanbang Biopharma (China)
  • Qingdao GD Biotechnology Pharmaceutical (China)
  • Aristo Pharmaceuticals (India)
  • Neiss Labs (India)
  • Ahaan Healthcare Pvt Ltd. (AHPL) (India)
Additional players considered in the study are as follows:
TTK HealthCare (India) , Incepta pharmaceuticals limited (Bangladesh) , Cadila (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation